385 related articles for article (PubMed ID: 17348440)
41. Spindle cell (sarcomatoid) carcinoma of the breast: a clinicopathologic and immunohistochemical analysis of 29 cases.
Carter MR; Hornick JL; Lester S; Fletcher CD
Am J Surg Pathol; 2006 Mar; 30(3):300-9. PubMed ID: 16538049
[TBL] [Abstract][Full Text] [Related]
42. Differential expression of estrogen, progesterone, and epidermal growth factor receptors in normal, benign, and malignant human breast tissues using dual staining immunohistochemistry.
van Agthoven T; Timmermans M; Foekens JA; Dorssers LC; Henzen-Logmans SC
Am J Pathol; 1994 Jun; 144(6):1238-46. PubMed ID: 7515559
[TBL] [Abstract][Full Text] [Related]
43. Invasive ductal carcinoma of the breast with the "triple-negative" phenotype: prognostic implications of EGFR immunoreactivity.
Viale G; Rotmensz N; Maisonneuve P; Bottiglieri L; Montagna E; Luini A; Veronesi P; Intra M; Torrisi R; Cardillo A; Campagnoli E; Goldhirsch A; Colleoni M
Breast Cancer Res Treat; 2009 Jul; 116(2):317-28. PubMed ID: 18839307
[TBL] [Abstract][Full Text] [Related]
44. Clinical significance of basal-like subtype in triple-negative breast cancer.
Yamamoto Y; Ibusuki M; Nakano M; Kawasoe T; Hiki R; Iwase H
Breast Cancer; 2009; 16(4):260-7. PubMed ID: 19701681
[TBL] [Abstract][Full Text] [Related]
45. Centrally necrotizing carcinoma of the breast: clinicopathological analysis of 33 cases indicating its basal-like phenotype and poor prognosis.
Yu L; Yang W; Cai X; Shi D; Fan Y; Lu H
Histopathology; 2010 Aug; 57(2):193-201. PubMed ID: 20716161
[TBL] [Abstract][Full Text] [Related]
46. Activated Akt signaling pathway in invasive ductal carcinoma of the breast: correlation with HER2 overexpression.
Park SS; Kim SW
Oncol Rep; 2007 Jul; 18(1):139-43. PubMed ID: 17549359
[TBL] [Abstract][Full Text] [Related]
47. Breast carcinoma with basal differentiation: a proposal for pathology definition based on basal cytokeratin expression.
Rakha EA; El-Sayed ME; Green AR; Paish EC; Lee AH; Ellis IO
Histopathology; 2007 Mar; 50(4):434-8. PubMed ID: 17448018
[TBL] [Abstract][Full Text] [Related]
48. Immunohistochemical study of TGF-alpha, TGF-beta1, EGFR, and IGF-1 expression in human breast carcinoma.
Pilichowska M; Kimura N; Fujiwara H; Nagura H
Mod Pathol; 1997 Oct; 10(10):969-75. PubMed ID: 9346175
[TBL] [Abstract][Full Text] [Related]
49. Triple negative, basal cell type and EGFR positive invasive breast carcinoma in Kuwaiti and British patients.
Ayad E; Francis I; Peston D; Shousha S
Breast J; 2009; 15(1):109-11. PubMed ID: 19077133
[No Abstract] [Full Text] [Related]
50. Basal phenotype of ductal carcinoma in situ: recognition and immunohistologic profile.
Dabbs DJ; Chivukula M; Carter G; Bhargava R
Mod Pathol; 2006 Nov; 19(11):1506-11. PubMed ID: 16941011
[TBL] [Abstract][Full Text] [Related]
51. The significance of combined CK5/6 and p63 immunohistochemistry in predicting the risks of subsequent carcinoma development in intraductal papilloma of the breast.
Yang Y; Suzuki K; Abe E; Li C; Uno M; Akiyama F; Yamauchi H; Kikuchi M; Ohde S; Deshpande G; Shibahara Y; Nakamura Y; Sasano H
Pathol Int; 2015 Feb; 65(2):81-8. PubMed ID: 25572436
[TBL] [Abstract][Full Text] [Related]
52. Value of p16(INK)⁴(a) in the pathology of invasive penile squamous cell carcinomas: A report of 202 cases.
Cubilla AL; Lloveras B; Alejo M; Clavero O; Chaux A; Kasamatsu E; Monfulleda N; Tous S; Alemany L; Klaustermeier J; Muñoz N; Quint W; de Sanjose S; Bosch FX
Am J Surg Pathol; 2011 Feb; 35(2):253-61. PubMed ID: 21263246
[TBL] [Abstract][Full Text] [Related]
53. Relationships between epidermal growth factor receptor (EGF-R) and other predictors of prognosis in breast carcinomas. An immunohistochemical study.
Martinazzi M; Crivelli F; Zampatti C; Martinazzi S
Pathologica; 1993; 85(1100):637-44. PubMed ID: 8170712
[TBL] [Abstract][Full Text] [Related]
54. Alteration of cyclin D1 in Chinese patients with breast carcinoma and its correlation with Ki-67, pRb, and p53.
Guo LL; Gao P; Wu YG; Jian WC; Hao CY; Li H; Lin XY
Arch Med Res; 2007 Nov; 38(8):846-52. PubMed ID: 17923265
[TBL] [Abstract][Full Text] [Related]
55. Value of P63 and CK5/6 in distinguishing squamous cell carcinoma from adenocarcinoma in lung fine-needle aspiration specimens.
Khayyata S; Yun S; Pasha T; Jian B; McGrath C; Yu G; Gupta P; Baloch Z
Diagn Cytopathol; 2009 Mar; 37(3):178-83. PubMed ID: 19170169
[TBL] [Abstract][Full Text] [Related]
56. Altered patterns of the interferon-inducible gene IFI16 expression in head and neck squamous cell carcinoma: immunohistochemical study including correlation with retinoblastoma protein, human papillomavirus infection and proliferation index.
Azzimonti B; Pagano M; Mondini M; De Andrea M; Valente G; Monga G; Tommasino M; Aluffi P; Landolfo S; Gariglio M
Histopathology; 2004 Dec; 45(6):560-72. PubMed ID: 15569046
[TBL] [Abstract][Full Text] [Related]
57. Prognostic significance of molecular classification of breast invasive ductal carcinoma.
Muñoz M; Fernández-Aceñero MJ; Martín S; Schneider J
Arch Gynecol Obstet; 2009 Jul; 280(1):43-8. PubMed ID: 19082617
[TBL] [Abstract][Full Text] [Related]
58. The immunohistochemically "ER-negative, PR-negative, HER2-negative, CK5/6-negative, and HER1-negative" subgroup is not a surrogate for the normal-like subtype in breast cancer.
Yu KD; Shen ZZ; Shao ZM
Breast Cancer Res Treat; 2009 Dec; 118(3):661-3. PubMed ID: 19714461
[No Abstract] [Full Text] [Related]
59. Risk factors for initial lung metastasis from breast invasive ductal carcinoma in stages I-III of operable patients.
Gao D; Du J; Cong L; Liu Q
Jpn J Clin Oncol; 2009 Feb; 39(2):97-104. PubMed ID: 19052036
[TBL] [Abstract][Full Text] [Related]
60. A subset of breast invasive ductal carcinoma with distinctive cytomorphology, aggressive clinical behavior, and unique immunologic profiles.
Lu D; Masood S; Khalbuss WE; Bui M
Cancer; 2002 Oct; 96(5):294-300. PubMed ID: 12378597
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]